Clinical impacts of genomic copy number gains at Xq28.
Toshiyuki YamamotoKeiko ShimojimaShino ShimadaKenji YokochiShinsaku YoshitomiKeiko YanagiharaKatsumi ImaiNobuhiko OkamotoPublished in: Human genome variation (2014)
Duplications of the Xq28 region are the most frequent chromosomal aberrations observed in patients with intellectual disability (ID), especially in males. These duplications occur by variable mechanisms, including interstitial duplications mediated by segmental duplications in this region and terminal duplications (functional disomy) derived from translocation with other chromosomes. The most commonly duplicated region includes methyl CpG-binding protein 2 gene (MECP2), which has a minimal duplicated size of 0.2 Mb. Patients with MECP2 duplications show severe ID, intractable seizures and recurrent infections. Duplications in the telomeric neighboring regions, which include GDP dissociation inhibitor 1 gene (GDI1) and ras-associated protein RAB39B gene (RAB39B), are independently associated with ID, and many segmental duplications located in this region could mediate these frequently observed interstitial duplications. In addition, large duplications, including MECP2 and GDI1, induce hypoplasia of the corpus callosum. Abnormalities observed in the white matter, revealed by brain magnetic resonance imaging, are a common finding in patients with MECP2 duplications. As primary sequence analysis cannot be used to determine the region responsible for chromosomal duplication syndrome, finding this region relies on the collection of genotype-phenotype data from patients.
Keyphrases
- copy number
- mitochondrial dna
- genome wide
- intellectual disability
- magnetic resonance imaging
- white matter
- dna methylation
- end stage renal disease
- autism spectrum disorder
- chronic kidney disease
- binding protein
- gene expression
- magnetic resonance
- newly diagnosed
- machine learning
- electronic health record
- early onset
- dna damage
- prognostic factors
- oxidative stress
- artificial intelligence
- resting state
- patient reported outcomes
- genome wide identification
- blood brain barrier
- data analysis
- contrast enhanced
- functional connectivity
- cerebral ischemia